Concepedia

Is first-line single-agent mitoxantrone in the treatment ofhigh-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial

E. Heidemann, Herbert Stoeger, Rainer Souchon, W. D. Hirschmann, H. Bodenstein, C. Oberhoff, Jörg Fischer, Markus Schulze, Michael Clemens, Reinhard Andreesen,

Annals of Oncology · 2002 · 49 citations · 33 references

DOI

Concepts

References

33

Nonparametric Estimation from Incomplete Observations

Edward L. Kaplan, Paul Meier · Journal of the American Statistical Association · 1958 · 39.1K citations

, , +10

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

Dennis J. Slamon, Brian Leyland‐Jones, Steven Shak et al. · New England Journal of Medicine · 2001 · 11.5K citations · Full text

, , +10

WHO handbook for reporting results of cancer treatment

Richard Sylvester · Controlled Clinical Trials · 1980 · 1.1K citations

, , +11

Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer.

Philip Greenberg, Gabriel N. Hortobágyi, Terry L. Smith et al. · Journal of Clinical Oncology · 1996 · 754 citations

, , +11

Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer

Stephen Chan, Kay Friedrichs, D. Noel et al. · Journal of Clinical Oncology · 1999 · 638 citations

, , +16